Antiretroviral therapy has resulted in significant declines in HIV-associated morbidity and mortality. However, new drugs continue to be needed to sustain and improve on this success. Fortunately, the HIV drug development pipeline is robust and numerous candidate antiretroviral drugs are in various stages of development. Here, we report on antiretroviral drugs in development, as well as new approaches to therapy that were presented at HIV DART 2006 Frontiers in Drug Development for Antiretroviral Therapies.
|Original language||English (US)|
|Number of pages||10|
|Journal||Drugs of the Future|
|State||Published - Jan 1 2007|
ASJC Scopus subject areas
- Pharmacology (medical)